Neurodermatitis: Clinical Trials

4 trials for Neurodermatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Not yet recruiting 1, Recruiting 1

Follow Neurodermatitis: new trials by email Literature Review of Neurodermatitis trials Research Report on Neurodermatitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.
PG-033 tablets, PG-033 placebo comparator - Lichen Simplex Chronicus
Phase 1Not yet recruitingPrime Gene Therapeutics Co., Ltd.302026-06-042026-06-01
A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults
PG-033, PG-033 placebo comparator - Lichen Simplex Chronicus
Phase 1RecruitingPrime Gene Therapeutics Co., Ltd.522025-05-232026-06-02
A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis
si-544, Placebo - Atopic Dermatitis
Phase 1CompletedselectION Therapeutics GmbH362022-08-302023-11-13
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
IMP Application KM-001, Chemistry, Hematology - Lichen Simplex Chronicus
Phase 1CompletedOrvida Pharma (formerly Kamari Pharma)552022-05-242024-04-02

Narrower conditions

Pruritus (2)  ·  Dermatitis, Atopic (1)

Broader conditions

Dermatitis (4)  ·  Skin Diseases (4)  ·  Skin Diseases, Eczematous (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Skin Manifestations (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Skin Diseases, Genetic (1)

Interventions

Electrocardiography (1)  ·  Hematologic Tests (1)  ·  Pregnancy Tests (1)  ·  Restraint, Physical (1)  ·  Urinalysis (1)

Sponsors

Prime Gene Therapeutics Co., Ltd. (2)  ·  Orvida Pharma (formerly Kamari Pharma) (1)  ·  selectION Therapeutics GmbH (1)

Countries

China (2)  ·  Germany (2)

Top investigators

Andreas Klostermann, Dr. (1)